The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Value Trend Is Expected For The CRISPR And Cas Gene Market From 2026 To 2030?
The crispr and cas gene market size has experienced significant expansion in recent years. This market is set to expand from $4.81 billion in 2025 to $5.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 21.8%. Historically, this growth can be attributed to the groundbreaking discovery of crispr cas systems, decreased gene editing costs, widespread adoption in academic research, the provision of research kits, and government financial backing.
The crispr and cas gene market is projected to undergo significant expansion in the coming years, with its size anticipated to reach $13.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.3%. This projected growth can be ascribed to factors such as the clinical application of gene editing, the broadening scope of personalized medicine, the proliferation of biotech startups, increased financial commitments to research, and progress in delivery methodologies. Prominent developments expected during this period include a wider array of gene editing research applications, increasing deployment in cell line engineering, greater integration into drug discovery, the creation of advanced crispr libraries, and a surge in custom gene editing services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp
What Are The Main Drivers Accelerating The Growth Of The CRISPR And Cas Gene Market?
The CRISPR and Cas gene markets are expected to see growth propelled by an increasing focus on personalized therapy. Personalized therapy describes a medical approach that utilizes an individual’s genetic profile to guide choices concerning disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, specifically Cas9, are employed in personalized medicine, allowing for precise modifications to an individual’s genetic material and showing potential for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based organization, in 2023, the FDA granted approval to 16 novel personalized therapies designed for rare disease patients, which was an increase from the six such treatments approved in 2022. Therefore, the growing demand for personalized therapy will drive the expansion of the CRISPR and Cas gene markets.
What Key Segment Areas Are Included In The CRISPR And Cas Gene Market Assessment?
The crispr and cas gene market covered in this report is segmented –
1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits
2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries
3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services
4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays
5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents
Which Trends Are Influencing The Direction Of The CRISPR And Cas Gene Market?
Leading firms within the CRISPR and Cas gene markets are actively creating innovative products, including CRISPR-based cell-based gene therapy, to broaden their product portfolios and gain a competitive edge. This CRISPR-based cell-based gene therapy involves employing the CRISPR gene-editing technology to alter or correct genetic material inside cells, thereby presenting a precise and potentially transformative approach to addressing genetic disorders, diseases, and various medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY functions as a CRISPR/Cas9 genome-edited gene therapy designed for the management of sickle cell disease (SCD) in individuals aged 12 and above who experience recurrent vaso-occlusive crises. This groundbreaking medication, CASGEVY, offers the prospect of a single, transformative therapy for eligible sickle cell patients. As CASGEVY administration necessitates specialized training in stem cell transplantation, Vertex is partnering with seasoned institutions to establish a network of independently owned, approved treatment centers (ATCs) throughout the United States to deliver CASGEVY to patients.
Which Industry Players Are Present In The CRISPR And Cas Gene Market?
Major companies operating in the crispr and cas gene market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc, Danaher Corporation, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, GenScript, Takara Bio Inc., Merck KGaA, Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc, New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc, Cellectis S.A., Editas Medicine Inc, CRISPR Therapeutics AG, Mammoth Biosciences, Inscripta Inc, Prime Medicine Inc, Precision BioSciences Inc, Sangamo Therapeutics Inc.
Access The Complete CRISPR And Cas Gene Market Report:
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report
Which Region Stands As The Largest Contributor To The CRISPR And Cas Gene Market?
North America was the largest region in the CRISPR and Cas gene market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access CRISPR And Cas Gene Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13632&type=smp
Browse Through More Reports Similar to the Global CRISPR And Cas Gene Market 2026, By The Business Research Company
Cranial Fixation And Stabilization Devices Global Market Report 2026
Cerebrospinal Fluid Management Csf Devices And Equipment Global Market Report 2026
Assistive Technologies For Visually Impaired Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model